These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Secretases as targets for the treatment of Alzheimer's disease]. Luo HM; Gu F Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):189-92. PubMed ID: 12889164 [No Abstract] [Full Text] [Related]
4. [Pathogenesis of Alzheimer's disease: implications from amyloid research front]. Iwatsubo T Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease: recent progress and prospects--Part II. Harv Ment Health Lett; 2001 Nov; 18(5):1-3. PubMed ID: 11977194 [No Abstract] [Full Text] [Related]
6. An inflammatory drug prospect. De Strooper B; König G Nature; 2001 Nov; 414(6860):159-60. PubMed ID: 11700538 [No Abstract] [Full Text] [Related]
7. Amyloid-beta precursor protein processing in neurodegeneration. Wilquet V; De Strooper B Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891 [TBL] [Abstract][Full Text] [Related]
11. Specific enzyme identified that snips APP into beta-amyloid. Senior K Drug Discov Today; 2005 Nov; 10(21):1408. PubMed ID: 16243255 [No Abstract] [Full Text] [Related]
20. gamma-Secretase as a target for drug intervention in Alzheimer's disease. Harrison T; Churcher I; Beher D Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]